Literature DB >> 8615077

Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype.

Y Robitaille1, L Schut, S J Kish.   

Abstract

Neuropathological investigations performed on autopsied brain and spinal cords from 11 patients showed that spinocerebellar ataxia type 1 (SCA-1) can be distinguished from autosomal dominant spinocerebellar ataxia linked to SCA-2 and -3 loci on chromosomes 12 and 14, spinopontine, and the multisystem atrophies. The major diagnostic criteria were: absence of significant pars compacta nigral and locus coeruleus lesions, severe degeneration of olivocerebellar and dentatorubral pathways, extensive loss of Purkinje cells with partial sparing of flocculonodular lobes, severe atrophy of specific cranial nerve nuclei, mostly the third and 12th, extensive loss of motor neurons in anterior horns and Clarke's columns, and lack of oligodendroglial or neuronal cytoplasmic cytoskeletal inclusions. None of the brains displayed any significant immunoreactivity for the amyloid precursor protein or beta-amyloid peptide throughout the cortex. In conclusion, the type and neuroanatomical distribution of structural lesions were similarly reproduced in all probands at the end stage of SCA-1, to the point that they appeared to constitute a unique phenotype.

Entities:  

Mesh:

Year:  1995        PMID: 8615077     DOI: 10.1007/bf00318569

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

Review 1.  The olivopontocerebellar atrophies: a review.

Authors:  B W Konigsmark; L P Weiner
Journal:  Medicine (Baltimore)       Date:  1970-05       Impact factor: 1.889

2.  Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguín, Cuba.

Authors:  G Orozco Diaz; A Nodarse Fleites; R Cordovés Sagaz; G Auburger
Journal:  Neurology       Date:  1990-09       Impact factor: 9.910

Review 3.  Epidemiology and clinical aspects of Machado-Joseph disease.

Authors:  J Sequeiros; P Coutinho
Journal:  Adv Neurol       Date:  1993

4.  [An autopsied case of type 2 Machado-Joseph's disease or spino-pontine degeneration].

Authors:  K Iwabuchi; H Nagatomo; T Tanabe; H Sakai; S Yagishita
Journal:  No To Shinkei       Date:  1993-08

5.  Olivopontocerebellar atrophy. A review of 117 cases.

Authors:  J Berciano
Journal:  J Neurol Sci       Date:  1982-02       Impact factor: 3.181

6.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Authors:  M I Papp; J E Kahn; P L Lantos
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

7.  Confirmation of the SCA-2 locus as an alternative locus for dominantly inherited spinocerebellar ataxias and refinement of the candidate region.

Authors:  I Lopes-Cendes; E Andermann; E Attig; F Cendes; S Bosch; M Wagner; F Gerstenbrand; F Andermann; G A Rouleau
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

Review 8.  [Linkage study of hereditary spinocerebellar ataxia, and probable correlation for the loci to the disease phenotypes].

Authors:  H Sasaki
Journal:  Rinsho Shinkeigaku       Date:  1993-12

9.  The gene for Machado-Joseph disease maps to human chromosome 14q.

Authors:  Y Takiyama; M Nishizawa; H Tanaka; S Kawashima; H Sakamoto; Y Karube; H Shimazaki; M Soutome; K Endo; S Ohta
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

10.  On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family.

Authors:  J J Martin; N Van Regemorter; L Krols; J M Brucher; T de Barsy; H Szliwowski; P Evrard; C Ceuterick; M J Tassignon; H Smet-Dieleman
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  33 in total

Review 1.  The complex clinical and genetic classification of inherited ataxias. I. Dominant ataxias.

Authors:  S Di Donato
Journal:  Ital J Neurol Sci       Date:  1998-12

2.  Swallowing in degenerative ataxias.

Authors:  L Ramio-Torrentia; E Gomez; D Genis
Journal:  J Neurol       Date:  2006-04-20       Impact factor: 4.849

3.  "Hairy baskets" associated with degenerative Purkinje cell changes in essential tremor.

Authors:  Cordelia R Erickson-Davis; Phyllis L Faust; Jean-Paul G Vonsattel; Sachin Gupta; Lawrence S Honig; Elan D Louis
Journal:  J Neuropathol Exp Neurol       Date:  2010-03       Impact factor: 3.685

Review 4.  The inherited ataxias and the new genetics.

Authors:  S R Hammans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

5.  Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Laszlo Zaborszky
Journal:  Neuroscientist       Date:  2015-05-22       Impact factor: 7.519

6.  Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias.

Authors:  Carmen Rodríguez-Cueto; Cristina Benito; Javier Fernández-Ruiz; Julián Romero; Mariluz Hernández-Gálvez; María Gómez-Ruiz
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

7.  Mosaicism of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type 1 and Machado-Joseph disease patients.

Authors:  P Maciel; I Lopes-Cendes; S Kish; J Sequeiros; G A Rouleau
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

Review 8.  The spinocerebellar ataxias: order emerges from chaos.

Authors:  Russell L Margolis
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

9.  Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.

Authors:  Megan S Keiser; Jeffrey H Kordower; Pedro Gonzalez-Alegre; Beverly L Davidson
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

Review 10.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.